ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer.
Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.